Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.06 by 200 percent. This is a 62.5 percent increase over losses of $(0.16) per share from the same period last year. The company reported $13.57 million in sales this quarter. This is a 7.44 percent increase over sales of $12.63 million the same period last year.